Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease

Blood

Volumn 99, Issue 7, 2002, Pages 2315-2323

  Szczepański, Tomasz ^b   Willemse, Marja J ^a,b   Brinkhof, Bas ^a,b   Van Wering, Elisabeth R ^a,b   Van Der Burg, Mirjam ^b   Van Dongen, Jacques J M ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALGORITHM; ARTICLE; CANCER RECURRENCE; CHILD; GENE REARRANGEMENT; GENE SEQUENCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SOUTHERN BLOTTING;

EID: 0036530196     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.7.2315     Document Type: Article

References (47)

1. A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse
2. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
3. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
4. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
5. New definition of remission in childhood acute lymphoblastic leukemia
6. Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: Alternative PCR targets for detection of minimal residual disease
7. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia
8. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional regions specific TaqMan probes
9. Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia
10. Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR
11. Immunoglobulin heavy-chain consensus probes for realtime PCR quantification of residual disease in acute lymphoblastic leukemia
12. Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias
13. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia
14. Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: Implications for monitoring minimal residual disease
15. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: Implications for the detection of minimal residual disease by polymerase chain reaction analysis
16. Characterisation of non-concordance in the T-cell receptor γ chain genes at presentation and clinical relapse in acute lymphoblastic leukemia
17. Assessment of clonal evolution at Ig/TCR loci in acute lymphoblastic leukaemia by single-strand conformation polymorphism studies and highly resolutive PCR derived methods: Implication for a general strategy of minimal residual disease detection
18. Clonal evolution as judged by immunoglobulin heavy chain gene rearrangements in relapsing precursor-B acute lymphoblastic leukemia
19. Proposals for the classification of the acute leukaemias
20. Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes
21. Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes
22. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia
23. Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia-proposal for an easy strategy
24. Immunoglobulin κ deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR
25. Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects
26. Detection of immunoglobulin heavy-chain gene rearrangements by Southern blot analysis: Recommendations for optimal results
27. Detection of immunoglobulin K lightchain gene rearrangement patterns by Southern blot analysis
28. Southern blot patterns, frequencies and junctional diversity of T-cell receptor 8 gene rearrangements in acute lymphoblastic leukemia
29. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: Implications for selection of PCR targets for detection of minimal residual disease
30. Heterogeneity in junctional regions of immunoglobulin κ deleting element rearrangements in B cell leukemias: A new molecular target for detection of minimal residual disease
31. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage
32. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations
33. The human immunoglobulin VH repertoire
34. Unravelling human T-cell receptor junctional region sequences
35. Ordered recombination of immunoglobulin light chain genes occurs at the IGK locus but seems less strict at the IGL locus
36. Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: Implications for basic and clinical research
37. T cell receptor γ (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect "end-stage" recombinations: Implications for minimal residual disease monitoring
38. Clinical relevance of T-cell receptor delta gene rearrangements in childhood B-precursor cell acute lymphoblastic leukaemia
39. Clonal diversity of Ig and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse
40. Acute lymphoblastic leukemia occurring as a second malignant neoplasm in childhood: Report of three cases and review of the literature
41. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia
42. VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia
43. Late relapsing childhood lymphoblastic leukemia
44. Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis
45. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy
46. Precursor-B-ALL with DH-JH gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14
47. T lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies